Page last updated: 2024-08-24

cidofovir anhydrous and Bronchiolitis Obliterans

cidofovir anhydrous has been researched along with Bronchiolitis Obliterans in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Baravalle-Einaudi, M; Bosdure, E; Dubus, JC; La Fay, C; Mazenq, J; Stremler-Le Bel, N1
Browning, M; Gaillard, EA; Ions, R; Narayanan, M; Stiefel, G; Tang, JW1

Other Studies

2 other study(ies) available for cidofovir anhydrous and Bronchiolitis Obliterans

ArticleYear
Severe adenovirus pneumonia with hemophagocytic syndrome and respiratory failure.
    Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 2020, Volume: 27, Issue:7

    Topics: Adenovirus Infections, Human; Antiviral Agents; Bronchiectasis; Bronchiolitis Obliterans; Chronic Disease; Cidofovir; Combined Modality Therapy; Humans; Infant; Lymphohistiocytosis, Hemophagocytic; Pneumonia, Viral; Respiration, Artificial; Respiratory Insufficiency; Severity of Illness Index

2020
Case presentation: persistent adenovirus B3 infections associated with bronchiolitis obliterans treated with cidofovir in a child with mosaic tetrasomy 9p.
    BMC infectious diseases, 2018, Oct-22, Volume: 18, Issue:1

    Topics: Adenoviridae; Adenoviridae Infections; Aneuploidy; Antiviral Agents; Bronchiolitis Obliterans; Chromosomes, Human, Pair 9; Cidofovir; Humans; Immunocompromised Host; Infant; Male; Mosaicism; Severity of Illness Index; Tomography, X-Ray Computed

2018